CalciMedica, Inc. (CALC)
NASDAQ: CALC · IEX Real-Time Price · USD
3.970
-0.160 (-3.87%)
Jul 22, 2024, 11:15 AM EDT - Market open
CalciMedica Employees
CalciMedica had 12 employees as of December 31, 2021.
Employees
12
Change
n/a
Growth
n/a
Revenue / Employee
n/a
Profits / Employee
-$1,244,917
Market Cap
44.18M
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2021 | 12 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| Qilian International Holding Group | 298 |
| Fortress Biotech | 186 |
| Carisma Therapeutics | 107 |
| BioXcel Therapeutics | 74 |
| Lucid Diagnostics | 70 |
| Envoy Medical | 34 |
| Matinas BioPharma Holdings | 32 |
| Regencell Bioscience Holdings | 12 |
CALC News
- 13 days ago - CalciMedica Announces First Patient Enrolled in Phase 2 KOURAGE Trial of Auxora™ in Severe Acute Kidney Injury (AKI) - PRNewsWire
- 14 days ago - CalciMedica Announces Presentations at Two Upcoming Healthcare Investment Conferences - PRNewsWire
- 21 days ago - CalciMedica Set to Join Russell Microcap® Index - PRNewsWire
- 25 days ago - CalciMedica Announces Positive Topline Data from Phase 2b CARPO Trial of Auxora™ in Acute Pancreatitis (AP) - PRNewsWire
- 25 days ago - CalciMedica to Host Conference Call to Review Topline Data from Phase 2b CARPO Trial of Auxora™ in Acute Pancreatitis (AP) - PRNewsWire
- 2 months ago - CalciMedica Reports First Quarter 2024 Financial Results and Provides Clinical & Corporate Updates - PRNewsWire
- 2 months ago - CalciMedica Announces Upcoming Presentation at Digestive Disease Week 2024 - PRNewsWire
- 3 months ago - CalciMedica Announces Last Patient Enrolled in Phase 2b CARPO Trial of Auxora™ in Acute Pancreatitis - PRNewsWire